Shares of Pulse Biosciences Inc (NASDAQ:PLSE) were up 23.4% during mid-day trading on Thursday . The company traded as high as $19.66 and last traded at $19.15. Approximately 500,098 shares traded hands during trading, an increase of 300% from the average daily volume of 125,083 shares. The stock had previously closed at $15.52.
A number of analysts have recently issued reports on PLSE shares. BidaskClub cut Pulse Biosciences from a “sell” rating to a “strong sell” rating in a research report on Wednesday, February 14th. ValuEngine upgraded Pulse Biosciences from a “sell” rating to a “hold” rating in a research report on Sunday, December 31st.
Pulse Biosciences (NASDAQ:PLSE) last released its quarterly earnings data on Friday, March 16th. The company reported ($0.53) earnings per share (EPS) for the quarter.
About Pulse Biosciences
Pulse Biosciences, Inc, formerly Electroblate, Inc, is a development-stage medical device company using a platform technology called Nano-Pulse Electro-Signaling (NPES). NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue.
Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.